本文へスキップ
Likelier

行動 vs. 不行動:各選択の数値

セラピーに通う vs. 専門的な助けを求めない

行動した場合

セラピーを受ける

27%

行動しなかった場合

セラピーを受けない

33%

少なくとも1つの数値は間接的な推定値であり、実際に測定した後悔の割合ではありません。各数値の算出方法は下に記載しています。


健康

最終確認 2026-06-14

証拠の質 4.25/5

8次元のレビュー評価。基準は 品質ルーブリック 。各次元は1〜5で評価。

D1 出典の検証
5/5
D2 出典の権威性と独立性
4/5
D3 後悔率の正確性
2/5
D4 出典の比較可能性
3/5
D5 ギロヴィッチ・パターン
5/5
D6 文章の質
5/5
D7 注意事項の完全性
5/5
D8 サンプルの質
5/5
平均 4.25/5
Two chairs facing each other across a small table, one side lit, one in shadow.
間接データ:この決断については、少なくとも1つの数値が、後悔を直接尋ねた調査ではなく、結果、満足度、意向といった間接的な指標、または編集部による推定に基づいています。各数値の算出方法は、下の各選択肢の注記に記載しています。

行動した場合

セラピーを受ける

27%

セラピー受講者の27%がセラピーは役立たなかったと回答(有用性ベース後悔の代替指標)

セラピーを受けた英国成人、全国代表

遡及的、期間は様々

行動しなかった場合

セラピーを受けない

33%

米国成人の非セラピー受診者の約33%が潜在的需要を表明(検討したが求めなかった — 不行動後悔の代替指標)

メンタルヘルスケアを求めたことのない米国成人、全国代表

横断的、2025年4月

各選択の数値(何を測ったかはページに明記)

関連する決断

意味的に類似する決断 — 同じ領域、異なるトレードオフ。

family

カップル療法 vs 受けない

各選択の数値(何を測ったかはページに明記)

lifestyle

タトゥー

各選択の数値(何を測ったかはページに明記)

健康

禁煙

各選択の数値(何を測ったかはページに明記)

健康

精管切除術

各選択の数値(何を測ったかはページに明記)

健康

依存症治療 vs 回避

各選択の数値(何を測ったかはページに明記)

健康

ボディピアス

各選択の数値(何を測ったかはページに明記)

family

子供を持つ

各選択の数値(何を測ったかはページに明記)

健康直接

割礼の決断

この選択を後悔した割合

均衡

ほぼ均衡

この決断の背後にあるリスク

この選択の根底にある確率。

Among UK adults who have had therapy, 27% did not find it helpful (BACP/YouGov 2025, n=5,150); among US adults who have never sought mental health care, approximately 33% express latent demand — they want care but have not pursued it (APA/Harris Poll 2025, n=1,076). The bilateral comparison is directionally consistent with Gilovich and Medvec’s inaction-dominance model, but the 6-percentage-point gap is computed from incomparable populations — UK therapy-attenders versus US non-attenders — and should not be read as a precise effect size. The pattern is classified as balanced: the signal points toward inaction carrying more regret, but the cross-national measurement gap prevents a stronger directional claim.

The data-quality limitations are layered. The action-side BACP figure is the stronger instrument: a large, nationally representative YouGov survey asking therapy-attenders to assess their own outcomes. Its weakness is framing — “not helpful” captures a broad range of outcomes from genuine harm to mild disappointment, and the 27% unhelpfulness rate sits well above the 5.2% lasting-harm rate found in Crawford et al.’s NHS patient survey (n=14,587), confirming that most of the 27% experienced disappointment rather than lasting damage. The inaction-side rate is a derived figure: 17% of all US adults said they want mental health care but have not sought it, out of 51% who had never sought care, yielding 33% latent demand among non-attenders. Latent demand is prospective (want to go) rather than retrospective (wish I had gone), which likely understates actual regret in older cohorts where the opportunity cost has already accumulated.

Two structural confounders qualify any strong directional claim. First, access barriers make much inaction involuntary: NHS England waiting lists, US insurance gaps, cost, and persistent stigma mean that a share of non-attenders who want care cannot readily obtain it, conflating structural barriers with personal decision regret. Second, cross-national asymmetry in the data — UK for the action side, US for the inaction side — introduces noise because NHS cost-free access and US insurance-dependent access produce different selection effects in who enters therapy and who doesn’t. Within those limits, the data are consistent with the established finding that long-run regret accumulates more on the side of inaction than action, though the effect size here is too small to carry strong causal weight.

出典: 行動

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

1/2 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] British Association for Counselling and Psychotherapy / YouGov — BACP Public Perceptions Survey 2025
    BACP Public Perceptions Survey 2025
    統計値
    73% of UK adults who have had therapy found it helpful; 27% did not
    抜粋
    “"Our survey found more than seven in 10 adults who’ve had therapy found it helpful (73%) and three quarters (75%) would recommend it to anyone looking for mental health support and to improve their wellbeing." ”
    出典データ
    2025-03-04
    アクセス日
    2026-05-01 · アーカイブ版
    計算過程
    BACP/YouGov 2025 Public Perceptions Survey (n=5,150 UK adults, nationally representative). 73% of therapy-attenders found therapy helpful, implying 27% did not (1 - 0.73 = 0.27). This is used as the action-side regret proxy: therapy-attenders who did not find treatment helpful are the subgroup most likely to regret having attended. "Not helpful" and "regret going" are not the same construct — a person can find therapy emotionally challenging but ultimately beneficial, and a person can find a single course unhelpful without regretting the attempt. The 27% figure likely overstates harm-based regret and understates indifference-based outcomes. D3 score: 3 (real survey measuring helpfulness, a recognized proxy for regret rather than a direct regret instrument). Used as the primary action-side rate because it is the largest nationally representative UK survey measuring therapy outcome from the patient's perspective.
  2. [2] British Journal of Psychiatry / Crawford et al. — Patient experience of negative effects of psychological treatment: results of a national survey 検証済み
    Patient experience of negative effects of psychological treatment: results of a national survey
    統計値
    5.2% of 14,587 NHS psychotherapy patients in England and Wales reported lasting negative effects from their psychological treatment
    抜粋
    “"Cross-sectional survey of people receiving psychological treatment from 184 services in England and Wales." [...] "Of 14 587 respondents, 763 (5.2%) reported experiencing lasting bad effects." ”
    出典データ
    2016-03-01
    アクセス日
    2026-05-02
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Crawford et al. (2016) surveyed 14,587 NHS patients who received psychotherapy across 184 services and found 5.2% reported lasting negative effects. This is the largest published national survey of therapy harm and provides a conservative floor for harm-based regret. The 5.2% rate sits well below the BACP 2025 "not helpful" figure of 27%, confirming that lasting harm is a smaller subcomponent of overall treatment dissatisfaction. This source corroborates that the action-side floor for serious harm-based regret is low. Included as a corroborating peer-reviewed source; the primary action-side rate (0.27) is drawn from the BACP 2025 survey.

出典: 不作為

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

1/1 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] American Psychological Association / The Harris Poll — Public Attitudes Toward Mental Health in the U.S. 検証済み
    Public Attitudes Toward Mental Health in the U.S.
    統計値
    17% of all US adults want mental health care in the future but have not yet sought it; 34% have never sought care and don't want to — yielding 17/(17+34) = 33% latent demand among non-attenders
    抜粋
    “"More adults said they have sought mental health care in the past (45%), and close to 1 in 5 said they want to in the future (17%). Only one-third of adults (34%) said they had never sought professional mental health care and do not want to." Survey of 1,076 U.S. adults ages 18+, conducted online by The Harris Poll in partnership with APA, April 18-21, 2025. ”
    出典データ
    2025-04-21
    アクセス日
    2026-05-01
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    APA/Harris Poll 2025 (n=1,076 US adults, nationally representative, April 18-21 2025). The survey identified three mutually exclusive groups: those who sought care in the past (45%), those who want to in the future but haven't (17%), and those who never sought and don't want to (34%). The remaining ~4% are likely currently in care or did not respond. Among non-attenders (17% + 34% = 51% of the sample), 17/51 = 33% express latent demand (want care but haven't sought it). This 33% is used as the inaction-side regret proxy: non-attenders with latent demand are the subgroup most likely to retrospectively regret not having sought help. Construct limitation: "want care in the future" is not equivalent to "regret not having gone already" — latent demand is a forward-looking aspiration, while regret is a backward-looking counterfactual. Access barriers (cost, insurance, availability) mean some latent demand reflects structural obstacles rather than personal decision regret. Cross-national note: this is US data, not UK; the UK setting for the action side has different access structures (NHS, means-tested IAPT waitlists). UK latent demand data were searched across BACP/YouGov, MIND UK, Mental Health Foundation, NHS APMS 2023-24, and Rethink Mental Illness; no comparable nationally representative instrument was found that asked non-attenders directly about latent demand. The APA/Harris estimate (33%) is broadly consistent with UK treatment-gap literature and is used here as the best available nationally representative proxy.

注意事項

Neither side of this entry carries a directly measured regret rate. The action-side 27% (BACP/YouGov 2025, n=5,150 UK adults) measures the fraction of therapy-attenders who did not find therapy helpful — "not helpful" and "regret going" are distinct constructs. A person can find therapy difficult or inconclusive without regretting the attempt, and can find a single course unhelpful while benefiting from later treatment. BACP is a professional association for therapists; its survey was commissioned by a body with a financial stake in therapy uptake, which may bias the "helpful" framing toward positive outcomes. The inaction-side 33% (APA/Harris Poll 2025, n=1,076 US adults) is a derived latent-demand rate: 17% of all US adults want care but haven't sought it, divided by 51% who have never sought care, gives 33% of non-attenders expressing forward-looking demand (the remaining ~4% are likely currently in care or did not respond to that question). Latent demand is not equivalent to backward-looking regret. A meaningful portion of inaction is involuntary: NHS waiting times (England), insurance gaps (US), cost barriers, and persistent stigma all constrain access regardless of the individual's preference. Cross-national asymmetry is a fundamental limitation: the action side uses UK data (BACP/YouGov, Crawford NHS) and the inaction side uses US data (APA/Harris). US insurance-dependent access and NHS cost-free access produce different selection effects in who enters therapy and who doesn't; the 6-percentage-point gap between incomparable populations should not be read as a precise effect size. The gilovich_pattern is therefore classified as balanced rather than inaction_dominates: the directional signal is consistent with Gilovich and Medvec's inaction-dominance model, but the cross-national measurement gap means the delta cannot support a stronger directional claim. Both populations show comparable therapy-uptake rates of approximately 35-45% lifetime.

生データ: /api/decisions.json

このデバイスで最近見た項目